NCT06808724 Clinical Influence of Different Surface Treatments on Implant Stabiity
| NCT ID | NCT06808724 |
| Status | Recruiting |
| Phase | — |
| Sponsor | International Piezosurgery Academy |
| Condition | Edentulous Alveolar Ridge |
| Study Type | OBSERVATIONAL |
| Enrollment | 32 participants |
| Start Date | 2025-01-31 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 32 participants in total. It began in 2025-01-31 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to monitor, within a cohort of patients requiring rehabilitation at two different sites in the premolar area, the primary and secondary stability of implants placed with different surface treatments: vacuum-plasma activation, ozonated oil and non-activated implants.
Eligibility Criteria
Inclusion Criteria: * Age older than 18 years old; * Indication for an implant-supported rehabilitation in the left and right upper premolar/first molar areas; * The area in which the implants will be placed must have had at least 6 months of healing; * No use of grafts or bone substitutes following tooth extraction; * Bone volume measuring at least 10 mm in height and 6 mm in width; * Absence or decision to not wear a removable prosthesis during the healing period; * Patients with good and stable oral hygiene; * Signed informed consent form. Exclusion Criteria: * Acute myocardial infarction within the previous six months; * Uncontrolled bleeding disorders; * Uncontrolled diabetes (HBA1c \> 7.5%); * Radiotherapy in the head-neck area in the previous 48 months; * Immunocompromised patients (es. AIDS / chemotherapy); * Current or previous treatment with antiresorptive drugs via intravenous injection; * Psychological or psychiatric disease; * Alcohol and /or drugs abuse; * Heavy smokers (more than 10 cigarettes / day); * Plaque index \>20% and/or bleeding on probing \>10% * Pregnant or breastfeeding patients; * Patients refusing to participate in follow-up checks.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06808724 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Edentulous Alveolar Ridge. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06808724 currently recruiting?
Yes, NCT06808724 is actively recruiting participants. Contact the research team at claudio@stacchi.it for enrollment information.
Where is the NCT06808724 trial being conducted?
This trial is being conducted at Trieste, Italy.
Who is sponsoring the NCT06808724 clinical trial?
NCT06808724 is sponsored by International Piezosurgery Academy. The trial plans to enroll 32 participants.